{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:21:29Z","timestamp":1761891689707,"version":"build-2065373602"},"reference-count":61,"publisher":"Wiley","issue":"24","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2018,12,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus vaccination (HPVV) prevents several types of cancer. The American Cancer Society recently established a goal that by 2026, 80% of adolescents will be up to date (UTD) before their 13th birthday. However, the number in need of vaccination to reach this goal is unknown. This study estimated the number of additional adolescents (11\u201012 years old) who need HPVV for 80% prevalence to be reached by 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study used de\u2010identified and publicly available data and exempt from institutional review board approval and informed consent. The 2016 National Immunization Survey for Teens was used to estimate the baseline HPVV prevalence. Linear growth to 80% HPVV prevalence by 2026 was applied to set intermediate targets. US Census Bureau data were used for population projections. This study estimated the cumulative number of additional adolescents 11 to 12 years old who would need to become UTD (ie, receive 2 doses) by first subtracting the number who would need to be vaccinated to achieve an intermediate target prevalence from the estimated number currently compliant and then summing these numbers between 2018 and 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nationwide, an additional 7.62 million males (95% confidence interval [CI], 6.78 million to 8.40 million) and an additional 6.77 million females (95% CI, 5.95 million to 7.55 million), aged 11 to 12 years, would need to receive 2 doses of the vaccine between 2018 and 2026 for 80% prevalence to be achieved. Most adolescents not UTD (80%) also needed to initiate vaccination, and more than 90% recently visited a health care provider.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>It is estimated that at least 14.39 million additional adolescents aged 11 to 12 years in the United States will need to receive 2 doses of HPVV for a UTD HPVV prevalence of 80% to be achieved by 2026. To reach this goal, improvements in facilitators of HPVV initiation, including physician recommendations and parental acceptability, are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cncr.31763","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T13:50:39Z","timestamp":1537969839000},"page":"4720-4730","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reaching 80% human papillomavirus vaccination prevalence by 2026: How many adolescents need to be vaccinated and what are their characteristics?"],"prefix":"10.1002","volume":"124","author":[{"given":"Stacey A.","family":"Fedewa","sequence":"first","affiliation":[{"name":"Surveillance and Health Services Research American Cancer Society Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Preiss","sequence":"additional","affiliation":[{"name":"Cancer Control Interventions American Cancer Society Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcie","family":"Fisher\u2010Borne","sequence":"additional","affiliation":[{"name":"Cancer Control Interventions American Cancer Society Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Goding Sauer","sequence":"additional","affiliation":[{"name":"Surveillance and Health Services Research American Cancer Society Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmedin","family":"Jemal","sequence":"additional","affiliation":[{"name":"Surveillance and Health Services Research American Cancer Society Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Saslow","sequence":"additional","affiliation":[{"name":"Cancer Control Interventions American Cancer Society Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv086"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6526a1"},{"key":"e_1_2_7_4_1","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz LE","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.1.7"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1735"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6549a5"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21392"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6633a2"},{"key":"e_1_2_7_10_1","unstructured":"Office of Disease Prevention and Health Promotion.Healthy People 2020: immunization and infectious diseases.https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives. Accessed December 6 2017."},{"key":"e_1_2_7_11_1","unstructured":"American Cancer Society.Mission: HPV Cancer Free.http:\/\/pressroom.cancer.org\/HPVcancerfreelaunch. Accessed June 8 2018."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922812468208"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26246"},{"volume-title":"National Immunization Survey\u2010Teen","year":"2017","author":"Centers for Disease Control and Prevention","key":"e_1_2_7_14_1"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29659"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2011.300600"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0950"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0267"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-0658"},{"key":"e_1_2_7_20_1","unstructured":"Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. A Report to the President of the United States From the President\u2019s Cancer Panel.Bethesda MD:National Cancer Institute;2014."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491613100106"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.006"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2488"},{"key":"e_1_2_7_24_1","first-page":"591","article-title":"Human papillomavirus vaccination coverage among adolescent girls, 2007\u20132012, and postlicensure vaccine safety monitoring, 2006\u20132013\u2014United States","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2011.138"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2015.10.003"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.062"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.11.076"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2012.02.007"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0442"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2015.10.007"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922811415104"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-1048"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2012.01.003"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedhc.2013.01.002"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3863"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.11.021"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-4257"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2017.11.001"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-018-0743-8"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2017.06.008"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-1067"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30099-7"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.15.47.19730-en"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1071\/SH10001"},{"key":"e_1_2_7_46_1","unstructured":"Centers for Disease Control and Prevention.Vaccines for Children program.https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/index.html. Accessed June 1 2018."},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.045"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922816660541"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.1302"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1150394"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6041"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303286"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-15-1159"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.5993\/AJHB.38.1.10"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-2921"},{"key":"e_1_2_7_56_1","first-page":"625","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2013","volume":"63","author":"Elam\u2010Evans LD","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2017.02.003"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1542"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.871204"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.22614"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.12.020"},{"key":"e_1_2_7_62_1","unstructured":"US Census Bureau.American FactFinder.https:\/\/factfinder.census.gov\/. Accessed June 1 2018."}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.31763","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.31763","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncr.31763","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.31763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:28:09Z","timestamp":1761884889000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.31763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":61,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018,12,15]]}},"alternative-id":["10.1002\/cncr.31763"],"URL":"https:\/\/doi.org\/10.1002\/cncr.31763","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"2018-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}